Navigation Links
European Commission's Joint Research Centre's annual report 2010

This report provides an overview of the activities, accomplishments and resources related to the JRC's work carried out during 2010 and includes figures on staff, budget and publications.

In her foreword, Commissioner Mire Geoghegan-Quinn, in charge of research, innovation and science, highlights the need for policy making based on the best possible advice and affirms that "the JRC has built an excellent reputation as a world-class provider of scientific and technical support to European policy makers and legislators". The Commissioner refers as well to the role of the JRC as a "trusted and truly independent voice advising us on what is on the horizon in order to take timely policy decisions".

JRC Director-General, Dominique Ristori, emphasizes JRC efforts to support the Europe 2020 policy priorities addressing major challenges such as health, safety and security.

Examples of JRC's results throughout the year are described, such as the European-wide electricity grid model, contributions to the car emissions regulations, the crisis response work to Haiti and the methods to measure mycotoxins in infant food.

Many other highlights of JRC's work in different areas, such as energy (including nuclear), safety of food and consumer products, open and competitive economy or sustainable management of natural resources can also be found in the report.

In addition, an overview is given of the JRC mission and its implementation, the scientific activities and relations with the outside world. It covers as well the JRC input to the various stages of the policy cycle: from anticipation and formulation to policy adoption, implementation and evaluation.


Contact: Elena Gonzalez Verdesoto
European Commission Joint Research Centre

Page: 1

Related biology technology :

1. Cyberonics Announces First Implant of AspireSR™ Seizure Response Product in European Trial
2. Saladax Biomedical, Inc. Announces European Commercialization Team
3. ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration
4. European Commission Approves DuPont Tender Offer to Acquire Danisco
5. Onyx Pharmaceuticals Announces Plans to Amend Phase 3 FOCUS Study for European Registration
6. BioStorage Technologies Appoints New Director of Business Development for European Operations
7. Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer
8. ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardts Disease
9. Reportlinker Adds Strategic Analysis of European Human Machine Interface (HMI) Market
10. Dendreon to Host Conference Call to Provide Updates on U.S. Commercialization Progress, European Strategy for PROVENGE, and Pipeline Progress
11. European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its ... 2018 in San Francisco, CA. The Summit brings together current and former FDA office ... directors and government officials from around the world to address key issues in device ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of ... award for Excellence in Volunteer Experience from US2020. , US2020’s mission is to ...
Breaking Biology Technology:
(Date:8/15/2017)...   ivWatch LLC , a medical device company focused on ... receipt of its ISO 13485 Certification, the global standard for medical ... Standardization (ISO®). ... Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as ...
(Date:5/23/2017)... the first robotic gym for the rehabilitation and functional motor sense evaluation ... Genoa, Italy . The first 30 robots will be available from ... . The technology was developed and patented at the IIT laboratories ... Technology thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
Breaking Biology News(10 mins):